Yu Jung Kim

机构：New Generation University College, Seoul National University Bundang Hospital, Gachon University Gil Medical Center, National University College · ORCID：0000-0002-5037-0523

发表论文 417 篇 · 总被引 9396 次 · h-index 47

代表论文

• Durvalumab plus etoposide–platinum in patients with epidermal growth factor receptor (EGFR)-mutated advanced NSCLC and neuroendocrine transformation after first-line osimertinib: ORCHARD (2026 · Lung Cancer · 被引 3)
• Osimertinib plus Gefitinib in Patients with EGFR -Mutated Advanced Non–Small Cell Lung Cancer and EGFR (C797X) Mutation Following First-Line Osimertinib: ORCHARD (2026 · Clinical Cancer Research · 被引 1)
• Osimertinib plus platinum-based chemotherapy in patients with EGFR-mutated advanced NSCLC post-progression on first-line osimertinib: ORCHARD (2026 · Clinical Lung Cancer)
• Central Nervous System Activity of Lazertinib in EGFR ‐Mutated NSCLC With Prior EGFR TKI Exposure: A Pooled Analysis of KCSG‐LU20‐15 and LU21‐01 (2026 · Thoracic Cancer)
• Shared evolutionary trajectories underlying carcinogenesis and metastasis in biliary tract cancer (2026 · npj Precision Oncology)
• Real-world treatment patterns in stage III and IV melanoma patients: insights from a global multi-center chart review study (2026 · Frontiers in Immunology)